• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NEURAVI LTD. UNK_THROMBECTOMY NEURAVI; CATHETER, THROMBUS RETRIEVER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NEURAVI LTD. UNK_THROMBECTOMY NEURAVI; CATHETER, THROMBUS RETRIEVER Back to Search Results
Catalog Number UNK_THROMBECTOMY NEURAVI
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Insufficient Information (4580)
Event Type  Death  
Manufacturer Narrative
Manufacturers ref.No: (b)(4).Information regarding patient identifier, date of birth, weight, race, ethnicity, and medical history were not provided.The date of death is not known.Date of event: the date of the event/study is not known.The product catalog and lot numbers are not available / not reported.The unique identifier (udi) and expiration date of the device is not known.Information such as initial reporter facility name, address, city, state, name, phone, and email address are not available / reported.The device manufacture date is not known as the product lot number of the device is not available / not reported.[conclusion]: it was reported through the database related research activities (drra) report source on behalf of the md-epidemiology, the following complications were reported in the drra potential complaint form and final study report (study number (b)(4)), aligned to a cerenovus product (embotrap (first or second generation) stent-retriever device) during the analysis years of july 2018  december 2020.It was reported that twenty-three (23) patients underwent a thrombectomy procedure with the embotrap stent-retriever (unknown product code/unknown lot #) device and per the discharge status indicator (for patients with primary diagnosis of acute ischemic stroke when embotrap was the only thrombectomy device) expired.Based on complaint information, the device was not available to be returned for analysis.The device lot number was not available.The manufacturing documentation review could not be performed without the lot number.Product analysis cannot be conducted as the product was not returned for analysis.In addition, there was no report of malfunction associated with the device.As such, the investigation will be closed.Since the relationship of death to the device cannot be excluded, the events meet the criteria for mdr reporting.With extremely limited information available, the cause of death is not known.There was no information on patient medical history, and no information on the device and its performance during use in the study procedure and no information related to concomitant devices used during the procedure.The device catalog and lot numbers are not known; therefore, the determination of possible device-related causes cannot be determined through device analysis or through device history record review.The exact cause of the event could not be conclusively determined.As part of the post market surveillance program, information from this complaint is trended for statistical signals and corrective/preventive action may be triggered at a later time.Since there was no evidence to suggest the event was related to a manufacturing or design issue, no corrective actions will be taken at this time.This is one of five products involved with the reported complaint.The associated manufacturer report numbers are: 3011370111-2021-00087, 3011370111-2021-00088, 3011370111-2021-00089, 3011370111-2021-00090, and 3011370111-2021-00091.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.The manufacturer will submit a supplemental report if new facts arise which materially alter information submitted in a previous mdr report.Additional information will be submitted within 30 days of receipt.
 
Event Description
It was reported through the database related research activities (drra) report source on behalf of the md-epidemiology, the following complications were reported in the drra potential complaint form and final study report (study number (b)(6)), aligned to a cerenovus product (embotrap (first or second generation) stent-retriever device) during the analysis years of july 2018  december 2020.It was reported that twenty-three (23) patients underwent a thrombectomy procedure with the embotrap stent-retriever (unknown product code/unknown lot #) device and per the discharge status indicator (for patients with primary diagnosis of acute ischemic stroke when embotrap was the only thrombectomy device) expired.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNK_THROMBECTOMY NEURAVI
Type of Device
CATHETER, THROMBUS RETRIEVER
Manufacturer (Section D)
NEURAVI LTD.
block 3
ballybritt business park
galway H91 K 5YD
EI  H91 K5YD
Manufacturer (Section G)
ADVANT MEDICAL
parkmore business park west
galway H91 P V0V
EI   H91 PV0V
Manufacturer Contact
gabriel alfageme
31 technology dr
irvine, CA 92618
949789-868
MDR Report Key12374574
MDR Text Key268426506
Report Number3011370111-2021-00087
Device Sequence Number1
Product Code NRY
Combination Product (y/n)N
PMA/PMN Number
K173452
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial
Report Date 08/19/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/26/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK_THROMBECTOMY NEURAVI
Was Device Available for Evaluation? No
Date Manufacturer Received08/19/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
-
-